Metabolic Profiling Reveals Diagnostic Biomarkers for Distinguishing Myocarditis From Acute Myocardial Infarction

Conclusions: In conclusion, patients experiencing AMI and MC undergo significant metabolic reprogramming. Metabolites exhibiting abnormal expression in peripheral blood hold diagnostic value for distinguishing between AMI and MC in clinical settings. 11-cis-retinol proved to be the pivotal biomarker...

Full description

Bibliographic Details

Published in:	Cardiovascular Therapeutics
Main Authors:	Yuting Chen, Xiu Liu, Chengying Hong, Shunyao Xu, Linling He, Zhenmi Liu, Huaisheng Chen, Yaowang Lin
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Online Access:	http://dx.doi.org/10.1155/cdr/6292099